F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on interview, medical record review, and policy review, the facility failed to ensure residents received
medications as ordered. This affected one (#20) of four residents reviewed for medications. The facility
census was 79.
Findings include:
Review of the medical record for Resident #20 revealed an admission date of 04/11/19. Diagnoses included
unspecified Alzheimer's disease, pseudobulbar effect, and unspecified anxiety disorder.
Review of Resident #20's physician orders revealed an order dated 08/07/22 for the narcotic pain
medication oxycodone five (5) milligrams (mg), to give 2.5 mg by mouth twice daily for knee pain.
Review of a progress noted dated 06/30/23 revealed Licensed Practical Nurse (LPN) #23 administered
oxycodone 5 mg instead of oxycodone 2.5 mg to Resident #20.
Interview on 08/21/23 at 1:59 P.M., LPN #23 verified she had made a medication error on 06/30/23 when
she gave Resident #20 a double dose of oxycodone by mistake. LPN #23 stated she thought she was
administering Resident #20's 5:00 P.M. dose of oxycodone 2.5 mg and 6:00 P.M. dose of the antianxiety
medication Ativan 0.5 mg when, in actuality, she removed the medications from two separate medication
cards of oxycodone 2.5 mg tablets. LPN #23 stated she did not notice her mistake until a few hours later
when she tried to reconcile the narcotics books and noticed the counts were off.
Review of policy titled, General Dose Preparation and Medication Administration, dated 12/01/07, revealed
the facility staff should verify that the medication name and dose are correct when compared to the
medication order of the medication administration record.
This deficiency represents non-compliance investigated under Complaint Number OH00145219.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365777
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365777
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/21/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Trinity Community
3218 Indian Ripple Road
Beavercreek, OH 45440
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, staff interview, and policy review, the facility failed to ensure that medications were stored
properly in medication carts. This affect one (#65) of eleven residents on the D-Hall with active prescriptions
for the pain medication Tylenol 500 milligram (mg) tablets. The facility census was 79.
Findings include:
Review of the medical record revealed Resident #65 admitted to the facility on [DATE] and had primary
diagnosis of unspecified rheumatoid arthritis.
Review of Resident #65's medical record revealed a physician order dated 01/18/23 for the pain medication
acetaminophen (Tylenol) 500 mg, one tablet by mouth three times daily for pain.
Observation on 08/21/2023 from 8:48 A.M. to 8:51 A.M. revealed, in the top drawer of the D-Hall medication
cart, a large plastic drinking cup labeled Tyle 500 with marker on the outside of the cup. Observed inside
the cup was an unspecified, but numerous, quantity of round white tablets, and the tablets were marked
with M2A4 57344. Licensed Practical Nurse (LPN) #136 administered four medications to Resident #65
including the antidepressant Cymbalta 60 mg, the stool softener Miralax 17 grams, the diuretic Aldactone
25 mg, and Tylenol 500 mg. LPN #136 took one of the round white tablets from the cup labeled Tyle 500
and administered it to Resident #65.
Interview on 08/21/2023 at 8:48 A.M., LPN#136 stated she was aware medications were not supposed to
be stored the way the round white tablets were stored during the observation on 08/21/23, and stated she
did not put the Tylenol in the medication cart like that. LPN #136 stated the medication was already stored
in the medication cart that way when she came on shift, and verified she did not normally work on that
medication cart.
Interview on 08/21/2023 at 9:19 A.M., the Director of Nursing (DON) stated she was not aware nurses were
storing medications inappropriately in the medication carts. The DON stated central supply ordered Tylenol
in large bottles that did not fit in the top drawer of the medication carts, but would start to order smaller
bottles.
Review of a policy titled, Storage and Expiration Dating of Medications and Biologicals, dated January
2022, revealed the facility should ensure that the medications and biologicals are stored in the containers in
which they were originally received.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365777
If continuation sheet
Page 2 of 2